MENU
VGHCX
AS OF
Mar 6 closing price
Price
$200.79
Change
-$1.57 (-0.78%)
Net Assets
40.19B
Intraday BUY SELL Signals
Go to the list of all blogs
Medtronic gets FDA approval for Accurian RF ablation platform - Zacks
Medtronic gets FDA approval for Accurian RF ablation platform - Zacks
Medtronic Plc recently announced the receipt of 510 k clearance from the FDA for its Accurian RF ablation platform. This clearance will help the company with its strategy to strengthen position in the huge chronic pain management market.
Related Ticker: VGHCX
Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Biogen (NASDAQ:BIIB).
Industry description
The investment seeks long-term capital appreciation.
The fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. The adviser may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest up to 50% of its assets in foreign stocks. It is non-diversified.
Market Cap
The average market capitalization across the Vanguard Health Care Inv MF is 285.61B. The market cap for tickers in the group ranges from 3.51M to 909.04B. LLY holds the highest valuation in this group at 909.04B. The lowest valued company is NOVN at 3.51M.
Volume
The average weekly volume growth across all stocks in the Vanguard Health Care Inv MF was 0%. For the same stocks of the MF, the average monthly volume growth was -99% and the average quarterly volume growth was -99%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 36
P/E Growth Rating: 50
Price Growth Rating: 52
SMR Rating: 47
Profit Risk Rating: 80
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the mutual fund lost 0.00%.
A.I. Advisor
published General Information
General Information
Category Health
Profile
Fundamentals
Details
Category
Health
Address
Vanguard Specialized FundsPo Box 2600 V26Valley Forge
Phone
6106696295
Web
www.vanguard.com
Interact to see
Advertisement
Advertisement